middle.news
Optiscan Raises $17.75m to Accelerate FDA Approval and Market Launch
1:03am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
Optiscan Raises $17.75m to Accelerate FDA Approval and Market Launch
1:03am on Saturday 30th of August, 2025 AEST
Key Points
Fully underwritten $17.75 million entitlement offer at $0.085 per share
Funds to support clinical studies and US FDA clearance for three medical devices
Substantial shareholder Peters Investments Pty Ltd underwriting and participating
Focus on developing flexible endomicroscope and robotic integration
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE